一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Analytical Chemistry>Reference Substance>Lapatinib Impurity13
Lapatinib Impurity13
  • Lapatinib Impurity13
  • Lapatinib Impurity13
  • Lapatinib Impurity13
  • Lapatinib Impurity13
  • Lapatinib Impurity13

Lapatinib Impurity13 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-12-16

Product Details

Product Name: Lapatinib Impurity13 CAS No.: 320337-48-2
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/12/16
Molecular formula: C26H19ClFN3O3

Lapatinib Impurity 13;320337-48-2

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

  • Product Number: L079013
    English Name: Lapatinib Impurity 13
    English Alias: (5-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methanol
    CAS Number: 320337-48-2
    Molecular Formula: C26H19ClFN3O3
    Molecular Weight: 475.90

  • Product Advantages: Lapatinib Impurity 13 has high purity and good stability. Its structure is confirmed by multiple precise analytical methods such as nuclear magnetic resonance and mass spectrometry, and it remains stable and uniform under different experimental environments and storage conditions. As a reference substance, it can provide accurate and reliable data for Lapatinib impurity detection, ensuring accurate and highly reproducible detection results, providing a solid guarantee for pharmaceutical quality research and quality control, and facilitating quality control in drug research and production processes.

  • Application Fields:

  • Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Lapatinib bulk drugs and formulations, ensuring that the sensitivity and specificity of the detection methods meet pharmaceutical quality standards and guaranteeing the consistency of drug quality.

  • Process Optimization: During the production of Lapatinib, by monitoring the content of this impurity and tracing the process steps of its generation, it helps to optimize the synthesis process, reduce impurity formation, and improve product quality and production efficiency.

  • Stability Studies: In drug stability tests, it analyzes the change trends of this impurity under different storage conditions (such as temperature, humidity, light), providing key data support for determining the shelf life and suitable storage conditions of drugs.


  • Background Description: Lapatinib is an important targeted drug for the treatment of HER2-positive breast cancer. In the process of its research, development, production, and quality control, impurity research is a key link to ensure drug safety and effectiveness. The presence of impurities may affect the efficacy and safety of the drug. As a related impurity of Lapatinib, in-depth research on Lapatinib Impurity 13 helps to comprehensively evaluate the quality of Lapatinib drugs, improve the drug quality evaluation system, and ensure the safety and effectiveness of clinical medication.

  • Research Status: Currently, research on Lapatinib Impurity 13 mainly focuses on detection technology and impurity generation mechanisms. In terms of detection technology, advanced methods such as Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) and high-resolution mass spectrometry are used to achieve precise detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors are analyzed by simulating drug synthesis reactions and storage environments, providing a theoretical basis for optimizing the production process and controlling impurities from the source. In addition, research on the impact of this impurity on the efficacy and safety of Lapatinib is also gradually being carried out

NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 




Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP3Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2026-06-12
VIP6Y
Sinoway Industrial co., ltd.
2026-06-22
VIP6Y
RongNa Biotechnology Co.,Ltd
2026-06-26
INQUIRY
新安县| 永吉县| 二连浩特市| 许昌县| 醴陵市| 玉山县| 吉安县| 拜城县| 绥德县| 修武县| 叶城县| 林甸县| 那曲县| 新蔡县| 济南市| 金阳县| 陵水| 塘沽区| 柳州市| 桦甸市| 略阳县| 翁牛特旗| 碌曲县| 渭源县| 星子县| 泾阳县| 军事| 砀山县| 鹿邑县| 镇康县| 陆河县| 滁州市| 邯郸县| 湄潭县| 甘德县| 岳池县| 淅川县| 南漳县| 金平| 白城市| 仁寿县|